<DOC>
	<DOCNO>NCT00452101</DOCNO>
	<brief_summary>The objective trial evaluate effect Aquamin F alone combination glucosamine sulfate versus placebo symptom joint pain , stiffness immobility subject painful osteoarthritis knee . The following hypothesis test : ( Hypothesis 1 ) After 12 week treatment , subject take Aquamin F alone combination glucosamine sulfate significantly less joint pain , stiffness immobility compare subject take glucosamine sulfate alone placebo alone . ( Hypothesis 2 ) No significant difference see adverse event subject take Aquamin F , glucosamine sulfate , Aquamin F + glucosamine sulfate placebo .</brief_summary>
	<brief_title>Effects Aquamin F Osteoarthritis Knee</brief_title>
	<detailed_description>Method : Subjects randomize receive 12 week Glucosamine sulfate v Aquamin F v Placebo v Aquamin F + Glucosamine sulfate control pain acetaminophen . Subjects follow blood chemistry measurement additional 12-week period specifically assess blood calcium level post treatment . All participant subject diet exercise regimen measurement include : WOMAC score ( pain , stiffness , mobility , total score ) , 6 Minute Walking Distances , active passive range motion measurement , DXA scan , blood chemistry , hematology , CRP level lipid profile well rescue medication diary measurement adverse event assessment . An independent statistician analyze data use independent t-tests ANCOVA between-group comparison matched-pair t-tests within-group comparison patient include ITT-LOCF completer analysis .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<criteria>Inclusion Criteria Subjects age 35 75 , male female Subjects diagnose symptomatic moderate severe osteoarthritis knee accord modify criteria American College Rheumatology17 , 18 Subjects present osteoarthritis knee judge symptom disability detectable publish , validated questionnaire previous diagnosis physician . Subjects symptomatic daily near daily pain stiffness osteoarthritis . Subjects screen WOMAC Osteoarthritis Index total score ( transform score ) 75 . Subjects ability comprehend complete questionnaire form . Subjects whose schedule permit clinic evaluation every four week . Subjects willing stop take calcium supplement , , restrict consumption high calcium food 600 mg ( two dairy serve ) per day Subjects high probability compliance study procedure test article consumption . Subjects willing able follow protocol guideline schedule , complete diary . Subjects likely abstain take unauthorized supplement participate clinical trial experimental treatment trial Subjects normal gastrointestinal digestion absorption . Exclusion Criteria Subjects suffer inflammatory arthritis , gout , pseudogout , Paget â€™ disease , seizure disorder , insulin dependent diabetes mellitus , uncontrolled hypertension , unstable cardiovascular disease , active hepatic renal disease , active cancer and/or HIV infection . Subjects nonambulatory bedridden due osteoarthritis . Subjects dependent prescription drug control pain . Subjects clinical trial experimental treatment past 3 month Subjects pregnant , lactating , risk become pregnant . Subjects receive : NonSteroidal AntiInflammatory Drugs ( NSAIDS ) within 48 hour prior study enrollment . Intramuscular systemic corticosteroid injection within 4 week prior study enrollment . Intraarticular corticosteroid injection within 2 month prior study enrollment . Intraarticular hyaluronic acid injection within 4 month prior study enrollment .</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2007</verification_date>
	<keyword>Osteoarthritis</keyword>
	<keyword>Clinical trial</keyword>
	<keyword>Aquamin F</keyword>
	<keyword>Glucosamine</keyword>
</DOC>